Delivery Order SPE2DB20D1100-SPE2DB25FB8H7

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,948.40 firm fixed-price delivery order is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $7,696.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical supplies, with a completion date of December 4, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,076.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566779957 ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of December 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract...
This federal contract award, valued at $9,606.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2025 and is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $10,694.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, under a firm fixed-price Delivery Order contract. The contract has an ultimate completion date of April 21, 2025. This award is not associated with a set-aside program and is open to full and open...
This federal contract award, valued at $17,249.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through March 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $2,108.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", a medical product, with a completion date of November 27, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $13,726.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of medical products, including a specific pharmaceutical product, ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $5,338.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of March 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, worth $1,157.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, and has an ultimate completion date of March 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB8H7
    Delivery Order

This federal contract award, valued at $2,669.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of April 21, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely part of the company's broader efforts to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/18/25, 10:08 AM